Richard Newitter
Stock Analyst at Truist Securities
(4.19)
# 482
Out of 4,984 analysts
382
Total ratings
51.32%
Success rate
14.39%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMCI Treace Medical Concepts | Maintains: Hold | $6.6 → $8 | $7.04 | +13.64% | 15 | Sep 4, 2025 | |
| MDT Medtronic | Maintains: Hold | $92 → $96 | $94.58 | +1.50% | 16 | Aug 21, 2025 | |
| CARL Carlsmed | Initiates: Buy | $18 | $15.06 | +19.52% | 1 | Aug 18, 2025 | |
| LNTH Lantheus Holdings | Downgrades: Hold | $111 → $63 | $50.84 | +23.92% | 19 | Aug 12, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Hold | $190 → $125 | $80.00 | +56.25% | 26 | Aug 5, 2025 | |
| SYK Stryker | Maintains: Hold | $410 → $415 | $376.88 | +10.11% | 21 | Aug 4, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $18 → $21 | $23.11 | -9.13% | 2 | Jul 30, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $145 → $137 | $102.69 | +33.41% | 8 | Jul 25, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $81 → $82 | $75.20 | +9.04% | 19 | Jul 25, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $120 → $125 | $98.50 | +26.90% | 17 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $600 | $433.66 | +38.36% | 29 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $24 | $12.18 | +97.04% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $102 | $76.44 | +33.44% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $365 | $322.22 | +13.28% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $80 → $68 | $56.22 | +20.95% | 27 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $125.62 | +9.06% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $140 → $135 | $82.10 | +64.43% | 5 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $70 | $37.28 | +87.77% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $51 | $30.02 | +69.89% | 3 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $19.25 | +24.68% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $19 | $14.80 | +28.38% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $172.20 | -15.80% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $99.92 | +13.09% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $256.29 | +11.20% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $14.71 | +42.76% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $8.96 | +123.21% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $77.20 | +6.22% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $187.57 | +33.28% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $4.62 | +462.77% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $129.44 | +494.87% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $68.20 | +24.63% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.67 | +57.85% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $16.82 | +60.52% | 5 | Feb 23, 2021 |
Treace Medical Concepts
Sep 4, 2025
Maintains: Hold
Price Target: $6.6 → $8
Current: $7.04
Upside: +13.64%
Medtronic
Aug 21, 2025
Maintains: Hold
Price Target: $92 → $96
Current: $94.58
Upside: +1.50%
Carlsmed
Aug 18, 2025
Initiates: Buy
Price Target: $18
Current: $15.06
Upside: +19.52%
Lantheus Holdings
Aug 12, 2025
Downgrades: Hold
Price Target: $111 → $63
Current: $50.84
Upside: +23.92%
Inspire Medical Systems
Aug 5, 2025
Downgrades: Hold
Price Target: $190 → $125
Current: $80.00
Upside: +56.25%
Stryker
Aug 4, 2025
Maintains: Hold
Price Target: $410 → $415
Current: $376.88
Upside: +10.11%
Beta Bionics
Jul 30, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $23.11
Upside: -9.13%
Integer Holdings
Jul 25, 2025
Maintains: Buy
Price Target: $145 → $137
Current: $102.69
Upside: +33.41%
Edwards Lifesciences
Jul 25, 2025
Maintains: Hold
Price Target: $81 → $82
Current: $75.20
Upside: +9.04%
Boston Scientific
Jul 24, 2025
Maintains: Buy
Price Target: $120 → $125
Current: $98.50
Upside: +26.90%
Jul 23, 2025
Maintains: Buy
Price Target: $590 → $600
Current: $433.66
Upside: +38.36%
Jun 16, 2025
Initiates: Hold
Price Target: $24
Current: $12.18
Upside: +97.04%
Jun 16, 2025
Initiates: Buy
Price Target: $102
Current: $76.44
Upside: +33.44%
Jun 16, 2025
Initiates: Buy
Price Target: $365
Current: $322.22
Upside: +13.28%
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $56.22
Upside: +20.95%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $125.62
Upside: +9.06%
May 1, 2025
Reiterates: Buy
Price Target: $140 → $135
Current: $82.10
Upside: +64.43%
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $37.28
Upside: +87.77%
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $30.02
Upside: +69.89%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $19.25
Upside: +24.68%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $14.80
Upside: +28.38%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $172.20
Upside: -15.80%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $99.92
Upside: +13.09%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $256.29
Upside: +11.20%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $14.71
Upside: +42.76%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $8.96
Upside: +123.21%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $77.20
Upside: +6.22%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $187.57
Upside: +33.28%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $4.62
Upside: +462.77%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $129.44
Upside: +494.87%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $68.20
Upside: +24.63%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.67
Upside: +57.85%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $16.82
Upside: +60.52%